Heteroanthracyclines. 1. 4-Demethoxyxanthodaunomycinone (6,7,9,11-tetrahydroxy-9-acetyl-7,8,9,10-tetrahydrobenzo(B)xanthen-12-one)
- 1 August 1983
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 61 (8) , 1788-1794
- https://doi.org/10.1139/v83-306
Abstract
Two heteroanthracyclinones, namely 4-demethoxyxanthodaunomycinone (29) and its epimer 4-demethoxy-7-epixantho-daunomycinone (30), were synthesized using 2-acetyl-5,8-dimethoxytetralin (12) as starting material. Condensation of 12 with 2-methoxybenzoic acid followed by hydrolysis and oxidative cyclization gave xanthones 17 and 18 which were converted to 19 and 20 for the purpose of separation and structure assignment by dipole moment. Hydrolysis of 19 followed by alkylation with chloromethyl methyl ether and oxidation with molecular oxygen gave 26 and 27, which on acid hydrolysis gave 4-demethoxyxanthodaunomycinone (29) and 4-demethoxy-7-epixanthodaunomycinone (30). Preliminary biological assays with MCF-7, a human breast cancer cell line, showed that both 29 and 30 were weakly active while daunomycinonc, the aglycone of 2, showed no activity under similar conditions.This publication has 2 references indexed in Scilit:
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.Proceedings of the National Academy of Sciences, 1979